Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
Andrew M.
-
June 17, 2020
0
Therma Bright Provides Update on Orpheus Medica Rapid Test for COVID-19 Virus in Saliva – CoviSafe(TM)
Andrew M.
-
July 16, 2020
0
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
0
Biotech News
Home
Biotech News
Biotech News
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis...
Paul Archie
-
October 20, 2020
0
Biotech News
Citius Pharmaceuticals Provides Updates on Mino-Lok® and CITI-002
BiotechStocktrader
-
December 19, 2018
0
Biotech News
Therma Bright Provides Corporate Update on the Saringer and Orpheus Transactions
Therma Bright Inc.
-
August 20, 2020
0
Biotech News
Generex Biotechnology Files Pre-IND Briefing Package with FDA for Ii-Key-SARS-CoV-2 Peptide...
Generex Biotechnology Corporation
-
July 20, 2020
0
1
2
3
...
22
Page 1 of 22
- Advertisement -
APPLE
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its...
Generex Biotechnology Corporation
-
August 17, 2020
0
Biotech News
CRANFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its Board of Directors (the...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Generex Biotechnology Corporation
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Generex Biotechnology Corporation
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Generex Biotechnology Corporation
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Generex Biotechnology Corporation
-
December 22, 2020
